Patiyan Andersson, Sally Dougall, Karolina Mercoulia, Kristy A. Horan, Torsten Seemann, Jake A. Lacey, Tuyet Hoang, Lex E.X. Leong, David Speers, Louise Cooley, Karina Kennedy, Rob Baird, Rikki Graham, Qinning Wang, Avram Levy, Dimitrios Menouhos, Norelle L. Sherry, Susan A. Ballard, Vitali Sintchenko, Amy V. Jennison, Benjamin P. Howden
{"title":"Effects of Decentralized Sequencing on National Listeria monocytogenes Genomic Surveillance, Australia, 2016–2023","authors":"Patiyan Andersson, Sally Dougall, Karolina Mercoulia, Kristy A. Horan, Torsten Seemann, Jake A. Lacey, Tuyet Hoang, Lex E.X. Leong, David Speers, Louise Cooley, Karina Kennedy, Rob Baird, Rikki Graham, Qinning Wang, Avram Levy, Dimitrios Menouhos, Norelle L. Sherry, Susan A. Ballard, Vitali Sintchenko, Amy V. Jennison, Benjamin P. Howden","doi":"10.3201/eid3113.241357","DOIUrl":null,"url":null,"abstract":"<p>We assessed turnaround times in the national <em>Listeria monocytogenes</em> genomic surveillance system in Australia before and after decentralized sequencing. Using 1,204 samples collected during 2016–2023, we observed statistically significant reductions in median time from sample collection to issuance of national genomic surveillance report to 26 days, despite sample numbers doubling in 2022 and 2023. During 2016–2018, all jurisdictions referred samples to the National Listeria Reference Laboratory for sequencing and analysis, but as jurisdictional sequencing capacity increased, 4 jurisdictions transitioned to sequencing their own samples and referring sequence data to the national laboratory. One jurisdiction had well-established genomics capacity, transitioned without noticeable disruption, and continued to improve. Another 3 jurisdictions initially had increased turnaround times, highlighting the need for defined sequence referral mechanisms. Overall, timeliness and throughput improved, and sequencing decentralization strengthened Australia’s genomic surveillance system while maintaining timeliness. The practices described could be beneficial and achievable in other countries.</p>","PeriodicalId":11595,"journal":{"name":"Emerging Infectious Diseases","volume":"103 1","pages":""},"PeriodicalIF":7.2000,"publicationDate":"2025-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Emerging Infectious Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3201/eid3113.241357","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
We assessed turnaround times in the national Listeria monocytogenes genomic surveillance system in Australia before and after decentralized sequencing. Using 1,204 samples collected during 2016–2023, we observed statistically significant reductions in median time from sample collection to issuance of national genomic surveillance report to 26 days, despite sample numbers doubling in 2022 and 2023. During 2016–2018, all jurisdictions referred samples to the National Listeria Reference Laboratory for sequencing and analysis, but as jurisdictional sequencing capacity increased, 4 jurisdictions transitioned to sequencing their own samples and referring sequence data to the national laboratory. One jurisdiction had well-established genomics capacity, transitioned without noticeable disruption, and continued to improve. Another 3 jurisdictions initially had increased turnaround times, highlighting the need for defined sequence referral mechanisms. Overall, timeliness and throughput improved, and sequencing decentralization strengthened Australia’s genomic surveillance system while maintaining timeliness. The practices described could be beneficial and achievable in other countries.
期刊介绍:
Emerging Infectious Diseases is a monthly open access journal published by the Centers for Disease Control and Prevention. The primary goal of this peer-reviewed journal is to advance the global recognition of both new and reemerging infectious diseases, while also enhancing our understanding of the underlying factors that contribute to disease emergence, prevention, and elimination.
Targeted towards professionals in the field of infectious diseases and related sciences, the journal encourages diverse contributions from experts in academic research, industry, clinical practice, public health, as well as specialists in economics, social sciences, and other relevant disciplines. By fostering a collaborative approach, Emerging Infectious Diseases aims to facilitate interdisciplinary dialogue and address the multifaceted challenges posed by infectious diseases.